Necessary Ventures
VC Fund
San Francisco, United States
Necessary Ventures is a VC fund in San Francisco focused on Health Care and Software. Necessary Ventures focuses on investing in what the world needs. They work with the founders to build the most scalable solutions.
- Total investments:
- 47
- Last investment:
- Lead investor:
- 9%
Last updated:
For AI agents: llms.txt
Industries Necessary Ventures invests in
Stages Necessary Ventures invests in
Countries Necessary Ventures invests in
Round sizes
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
4 more contacts available
Round size
- Seed
- $3M–$9.3M
- Pre-Seed
- $125k–$3.3M
- Series A
- $9M–$28M
Investment Focus
Industry
- Health Care 12 (26%)
- Software 7 (15%)
- Artificial Intelligence 7 (15%)
- Financial Services 4 (9%)
- Consumer 3 (6%)
Stage
- Seed 15 (32%)
- Series A 15 (32%)
- Pre-Seed 6 (13%)
- Series B 4 (9%)
- Series C 3 (6%)
Country
- United States 31 (66%)
- Nigeria 1 (2%)
- Venezuela 1 (2%)
- United Kingdom 1 (2%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
Neil Devani
Founder and Managing Partner
|
Founder and Managing Partner | Total investments: 6 | Find email |
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Kanurra
|
Kanurra is a pass-through pharmacy benefit manager for self-funded and level-funded companies that focuses on removing PBM spread, rebate retention, and other hidden costs. | $6.4M / Seed / Jul 27, 2026 | |
Arc Boats
|
Arc Boats is electrifying the world of boating, starting with high-performance watersport boats. | $50M / Series C / Mar 19, 2026 | |
Nitra
|
Nitra offers expense management software that integrates with the banks to provide innovative loan products. | $50M / Series B / Mar 10, 2026 | |
VERUSTRUCT
|
Verustruct formerly Impact3D. VERUSTRUCT is a tech company that provides 3D construction technology that delivers smart building solutions, sustainable engineering, and advanced construction automation. | $2.4M / Pre-Seed / Sep 24, 2025 | |
Copper
|
Copper is a a battery solutions startup. | $28M / Series A / Aug 27, 2025 | |
Brellium
|
Brellium is an AI-powered clinical note auditor that conducts note audits according to clients' clinical and billing standards, resulting in cost savings. | $16.7M / Series A / Mar 17, 2025 | |
Infinite Machine
|
Infinite Machine is to create the world's most captivating non-auto vehicles. Infinite Machine initial product, the P1, is a revolutionary new personal electric vehicle that combines innovative performance and usefulness with an industrial-style look. In Infinite Machine's ideal post-car future, environment and people coexist together. | $9.3M / Seed / Oct 29, 2024 | |
Nevoya
|
Nevoya's focus on zero-emission freight transport is a significant step toward sustainability in the logistics industry. Nevoya is an electric truckload carriers can help reduce the carbon footprint of shipping while also potentially lowering operational costs in the long run. | $3M / Seed / Sep 30, 2024 | |
Plural Energy
|
Plural Energy helps investors invest directly in renewable energy projects. The company utilizes blockchain-enabled smart contracts to provide constant yield and liquidity to investors. | $2.3M / Pre-Seed / May 30, 2024 | |
Unlearn.AI
|
Unlearn.AI is a biotech AI company that develops a digital twin service for clinical trials. Digital twins enhance healthcare by assessing health risks before a disease manifests its symptoms, according to some experts. Unlearn brings together a world-class team of experts across pharma, medtech, machine learning, and business who share a visionof using machine learning and biostatistics to improve clinical trials for the benefit of patients and sponsors.Unlearn invented their TwinRCT solution to enable biopharma partners to run faster, more successful clinical trials. A TwinRCT is a randomized trial that uses machine learning to achieve a higher probability of success with a smaller number of patients. As in a traditional RCT, patients are randomized to a treatment group and a control group, but, unlike a traditional trial, a prognostic digital twin is created for every patient using a machine learning model trained on historical data. The treatment effects for the primary and secondary outcomes can all be estimated from the trial with greater precision after correcting for a prognostic score derived for each patient's digital twin.TwinRCTs provide a scientifically-sound method for using deep learning and historical patient data to improve clinical trials. | $50M / Series C / Feb 08, 2024 | |
| See all 47 investments → | |||
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar country
Featured in Investor Lists
Recommended lists
FAQ
What does Necessary Ventures invest in?
Necessary Ventures invests primarily in Health Care, Software and Artificial Intelligence startups, most often at Seed and Series A stage. Most of the 47 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What is Necessary Ventures's check size?
Necessary Ventures typically joins rounds of $3M–$9.3M at Seed, $125k–$3.3M at Pre-Seed and $9M–$28M at Series A. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds Necessary Ventures participates in.
How do I contact Necessary Ventures?
Public channels for Necessary Ventures include LinkedIn, X (Twitter) and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at Necessary Ventures?
The team at Necessary Ventures includes Neil Devani (Founder and Managing Partner). The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
